Sonam Ltd
NSE:SONAMLTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sonam Ltd
NSE:SONAMLTD
|
IN |
|
S
|
Sarthak Metals Ltd
NSE:SMLT
|
IN |
|
Accenture PLC
NYSE:ACN
|
IE |
|
Shanghai Film Co Ltd
SSE:601595
|
CN |
|
Arcelik AS
IST:ARCLK.E
|
TR |
|
Y
|
Yantai North Andre Juice Co Ltd
SSE:605198
|
CN |
|
Amazia Inc
TSE:4424
|
JP |
|
Yamazaki Baking Co Ltd
TSE:2212
|
JP |
|
I
|
Integrated Design & Engineering Holdings Co Ltd
TSE:9161
|
JP |
|
Willow Biosciences Inc
TSX:WLLW
|
CA |
|
C
|
Ching Feng Home Fashions Co Ltd
TWSE:9935
|
TW |
|
Shoulder Innovations Inc
NYSE:SI
|
US |
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
CN |
|
A
|
Arctic Blue Beverages AB
STO:ARCTIC
|
SE |
Balance Sheet
Balance Sheet Decomposition
Sonam Ltd
Sonam Ltd
Balance Sheet
Sonam Ltd
| Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
3
|
2
|
1
|
2
|
4
|
|
| Cash Equivalents |
3
|
2
|
1
|
2
|
4
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
30
|
|
| Total Receivables |
183
|
115
|
114
|
130
|
163
|
|
| Accounts Receivables |
88
|
54
|
73
|
90
|
101
|
|
| Other Receivables |
95
|
60
|
42
|
40
|
63
|
|
| Inventory |
182
|
248
|
197
|
165
|
279
|
|
| Other Current Assets |
4
|
4
|
4
|
53
|
1
|
|
| Total Current Assets |
372
|
369
|
316
|
351
|
478
|
|
| PP&E Net |
465
|
541
|
537
|
506
|
496
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
496
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
162
|
|
| Note Receivable |
2
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
5
|
5
|
2
|
|
| Total Assets |
840
N/A
|
911
+8%
|
858
-6%
|
862
+0%
|
977
+13%
|
|
| Liabilities | ||||||
| Accounts Payable |
32
|
62
|
17
|
3
|
84
|
|
| Accrued Liabilities |
6
|
5
|
3
|
5
|
10
|
|
| Short-Term Debt |
189
|
200
|
197
|
161
|
152
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
29
|
20
|
|
| Other Current Liabilities |
22
|
16
|
14
|
24
|
28
|
|
| Total Current Liabilities |
250
|
284
|
231
|
222
|
294
|
|
| Long-Term Debt |
103
|
98
|
61
|
32
|
12
|
|
| Deferred Income Tax |
41
|
44
|
42
|
39
|
40
|
|
| Other Liabilities |
4
|
3
|
1
|
2
|
1
|
|
| Total Liabilities |
398
N/A
|
429
+8%
|
335
-22%
|
295
-12%
|
347
+18%
|
|
| Equity | ||||||
| Common Stock |
100
|
100
|
200
|
200
|
200
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
234
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
73
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
123
|
|
| Other Equity |
342
|
382
|
322
|
366
|
430
|
|
| Total Equity |
442
N/A
|
482
+9%
|
523
+8%
|
567
+8%
|
630
+11%
|
|
| Total Liabilities & Equity |
840
N/A
|
911
+8%
|
858
-6%
|
862
+0%
|
977
+13%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
20
|
40
|
40
|
40
|
40
|
|